FindTrial
Sign In

Study of Peripheral Blood cfDNA as Diagnosis and Prognosis Biomarker for Acute Pancreatitis

Study of Peripheral Blood cfDNA as Diagnosis and Prognosis Biomarker for Acute Pancreatitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-17012200
Enrollment
Unknown
Registered
2017-07-31
Start date
2017-06-02
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pancreatitis

Interventions

Gold Standard:Enhanced abdominal CT
Index test:Cell-free DNA

Sponsors

The First Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1)18 Years and older (2)Male or female (3)Patients who was diagnosed acute pancreatitis

Exclusion criteria

Exclusion criteria: (1)Symptoms of acute pancreatitis present for more than 24 hours (2)Age under 18 years (3)Pregnancy (4)patients unable to consent

Design outcomes

Primary

MeasureTime frame
Severe Acute Pancreatitis;—

Secondary

MeasureTime frame
organ injury;—

Countries

China

Contacts

Public ContactMengtao Zhou

The First Affiliated Hospital of Wenzhou Medical University

zmt0417@hotmail.com+86 13806697558

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026